Kevin C Chung1, Daniel Saddawi-Konefka, Steven C Haase, Gautam Kaul. 1. Ann Arbor, Mich. From the Section of Plastic Surgery, Department of Surgery, University of Michigan Health System; the University of Michigan Medical School; and the University of Michigan's Stephen M. Ross School of Business.
Abstract
BACKGROUND: Lower extremity trauma is common. Despite an abundance of literature on severe injuries that can be treated with salvage or amputation, the appropriate management of these injuries remains uncertain. In this situation, a cost-utility analysis is an important tool in providing an evidence-based practice approach to guide treatment decisions. METHODS: Costs following amputation and salvage were derived from data presented in a study that emerged from the Lower Extremity Assessment Project. The authors extracted relevant data on projected lifetime costs and analyzed them to include discounting and sensitivity analysis by considering patient age. The utilities for the various health states (amputation or salvage, including possible complications) were measured previously using the standard gamble method and a decision tree simulation to determine quality-adjusted life-years. RESULTS: Amputation is more expensive than salvage, independently of varied ongoing prosthesis needs, discount rate, and patient age at presentation. Moreover, amputation yields fewer quality-adjusted life-years than salvage. Salvage is deemed the dominant, cost-saving strategy. CONCLUSION: Unless the injury is so severe that salvage is not a possibility, based on this economic model, surgeons should consider limb salvage, which will yield lower costs and higher utility when compared with amputation.
BACKGROUND: Lower extremity trauma is common. Despite an abundance of literature on severe injuries that can be treated with salvage or amputation, the appropriate management of these injuries remains uncertain. In this situation, a cost-utility analysis is an important tool in providing an evidence-based practice approach to guide treatment decisions. METHODS: Costs following amputation and salvage were derived from data presented in a study that emerged from the Lower Extremity Assessment Project. The authors extracted relevant data on projected lifetime costs and analyzed them to include discounting and sensitivity analysis by considering patient age. The utilities for the various health states (amputation or salvage, including possible complications) were measured previously using the standard gamble method and a decision tree simulation to determine quality-adjusted life-years. RESULTS: Amputation is more expensive than salvage, independently of varied ongoing prosthesis needs, discount rate, and patient age at presentation. Moreover, amputation yields fewer quality-adjusted life-years than salvage. Salvage is deemed the dominant, cost-saving strategy. CONCLUSION: Unless the injury is so severe that salvage is not a possibility, based on this economic model, surgeons should consider limb salvage, which will yield lower costs and higher utility when compared with amputation.
Authors: Ellen J MacKenzie; Alison Snow Jones; Michael J Bosse; Renan C Castillo; Andrew N Pollak; Lawrence X Webb; Marc F Swiontkowski; James F Kellam; Douglas G Smith; Roy W Sanders; Alan L Jones; Adam J Starr; Mark P McAndrew; Brendan M Patterson; Andrew R Burgess Journal: J Bone Joint Surg Am Date: 2007-08 Impact factor: 5.284
Authors: Michael J Bosse; Melissa L McCarthy; Alan L Jones; Lawrence X Webb; Stephen H Sims; Roy W Sanders; Ellen J MacKenzie Journal: J Bone Joint Surg Am Date: 2005-12 Impact factor: 5.284
Authors: Michael J Bosse; Ellen J MacKenzie; James F Kellam; Andrew R Burgess; Lawrence X Webb; Marc F Swiontkowski; Roy W Sanders; Alan L Jones; Mark P McAndrew; Brendan M Patterson; Melissa L McCarthy; Thomas G Travison; Renan C Castillo Journal: N Engl J Med Date: 2002-12-12 Impact factor: 91.245
Authors: Ellen J MacKenzie; Michael J Bosse; Andrew N Pollak; Lawrence X Webb; Marc F Swiontkowski; James F Kellam; Douglas G Smith; Roy W Sanders; Alan L Jones; Adam J Starr; Mark P McAndrew; Brendan M Patterson; Andrew R Burgess; Renan C Castillo Journal: J Bone Joint Surg Am Date: 2005-08 Impact factor: 5.284
Authors: Ellen J MacKenzie; Michael J Bosse; James F Kellam; Andrew R Burgess; Lawrence X Webb; Marc F Swiontkowski; Roy Sanders; Alan L Jones; Mark P McAndrew; Brendan Patterson; Melissa L McCarthy; Charles A Rohde Journal: J Trauma Date: 2002-04
Authors: Melissa L McCarthy; Ellen J MacKenzie; David Edwin; Michael J Bosse; Renan C Castillo; Adam Starr Journal: J Bone Joint Surg Am Date: 2003-09 Impact factor: 5.284
Authors: Corinne Bunn; Sujay Kulshrestha; Bianca Di Chiaro; Uma Maduekwe; Zaid M Abdelsattar; Marshall S Baker; Fred A Luchette; Sonya Agnew Journal: J Am Coll Surg Date: 2021-04-20 Impact factor: 6.532
Authors: D S Edwards; Rhodri D Phillip; Nick Bosanquet; Anthony M J Bull; Jon C Clasper Journal: Clin Orthop Relat Res Date: 2015-09 Impact factor: 4.176